Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway

Castration-resistant prostate cancer (CRPC) is a progressed stage of prostate cancer, which requires better understanding of the mechanisms and remains an unmet clinical need. As a common oncogene, K-Ras is associated with malignant behavior in different types of tumors but its role in CRPC is unkno...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Liu, Jiayu, Zheng, Yongbo, Gao, Yingying, Quan, Zhen, Qiao, Bo, Li, Luo, Li, Ting, Duan, Limei, Yang, Jinxiao, Luo, Chunli, Wu, Xiaohou
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7051985/
https://ncbi.nlm.nih.gov/pubmed/32158687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00075
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller